Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06631404

Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
55 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers

Summary

Systemic Lupus Erthymatosous (SLE) is achronic inflammatory multi system auto immue disease characterized by pathogenic auto anti bodies production against nuclear structures (Bolouri et al.,2022), SLE affecting mainly woemn of childbearing age and is chracterized by unpredictable flares and remissions , disease variety varied from mild episode disorder to arpidly progressive life -threatening illness.. LN is diagnosed by either the presence of proteinuria \>0.5g/day. active urinary sediment , or an unexplained rise in serum creatinine there fore , identifying new invasive biomarkers of LN severity and outcome is mandatory, Renal Arterial resistive index ( RRI) is anon invasive biomarker that has been studied as apotential indicator of disease activity in LN patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTrenal dopplerdoppler srudy on renal arteries bilaterally , and detection of RI of renal artery

Timeline

Start date
2024-10-01
Primary completion
2025-10-30
Completion
2025-10-30
First posted
2024-10-08
Last updated
2024-10-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06631404. Inclusion in this directory is not an endorsement.